-
VX-661: F508del CFTR Corrector Workflow Guide
2026-09-01
Learn how to use VX-661 to separate CFTR trafficking rescue from channel potentiation in reproducible cell-based assays. This workflow combines practical dosing, orthogonal readouts, calnexin-aware variant testing, and troubleshooting for cystic fibrosis research.
-
Peptidisc-Assisted Nanobody Polybody Engineering
2026-09-01
A 2025 bioRxiv preprint introduces peptidisc-assisted hydrophobic clustering as a route to multimeric, bispecific, and autofluorescent nanobody assemblies. The resulting polybodies exploit avidity to improve binding performance while avoiding the need for conventional tandem linkers or large oligomerization scaffolds.
-
Prednisolone: Designing Interpretable GR Assays
2026-08-31
Prednisolone is a synthetic glucocorticoid for mechanistic glucocorticoid signaling research, inflammation modulation, and immunology research. This guide explains how to pair receptor-focused assays with ERAD studies without confusing transcriptional effects with targeted membrane-protein degradation.
-
N6-Methyl-dATP for Polymerase Assay Design
2026-08-31
N6-Methyl-dATP enables controlled analysis of methylated nucleotide recognition, DNA replication fidelity, and genomic stability. This article connects its biochemical use to assay decisions informed by the LMO2–LDB1 AML study, without conflating nucleotide chemistry with leukemia mechanism.
-
HDAC6, α-Tubulin Lactylation, and Microtubule Dynamics
2026-08-30
The reference study identifies α-tubulin lysine 40 lactylation as a previously unrecognized component of the tubulin code and shows that HDAC6 can catalyze this modification in a lactate-dependent manner. Its findings connect cellular metabolism with microtubule dynamics, neurite outgrowth, and branching while providing a framework for studying non-histone protein lactylation.
-
NHS-Biotin for Nanobody Assay Engineering
2026-08-29
NHS-Biotin adds a stable, streptavidin-readable tag to antibodies, nanobodies, and other amine-containing proteins without serving as the clustering mechanism itself. Used alongside peptidisc-assisted assembly, it helps distinguish genuine multimer formation from recovery, capture, or detection artifacts.
-
Lumiracoxib for Reliable COX-2 Assays
2026-08-28
Learn how Lumiracoxib, SKU B1458, can improve experimental control in COX-2 pathway, viability, inflammation, and revascularization studies. This scenario-based guide covers assay interpretation, solvent compatibility, time-dependent dosing, and practical supplier selection.
-
Peptidisc-Assisted Nanobody Multimerization
2026-08-28
Chen and Duong van Hoa describe a peptidisc-assisted strategy that uses transmembrane-segment-driven hydrophobic clustering to assemble nanobodies into soluble multimeric and multispecific proteins. The resulting polybodies improved target binding through avidity and extended the approach to bispecific and autofluorescent assemblies, while also defining important questions about oligomeric homogeneity and transferability.
-
ddhCTP: A Mechanistic Probe for RNA Virus Assays
2026-08-27
ddhCTP and 3ʹ-deoxy-3′,4′-didehydro-CTP provide a precise way to investigate RNA polymerase-dependent viral genome synthesis. This article explains how to use the metabolite as a mechanistic probe while distinguishing chain termination from viperin-mediated disruption of coronavirus replication complexes.
-
EZ Cap™ Firefly Luciferase mRNA Workflow
2026-08-27
Build sensitive reporter experiments around Cap1-capped, polyadenylated luciferase mRNA for delivery, translation, viability, and imaging studies. This workflow separates delivery performance from transcriptional effects and shows how redox-aware LNP testing can improve assay interpretation.
-
SB525334: TGF-β1 Across Repair and Fibrosis
2026-08-26
SB525334 is a selective TGF-beta1 receptor inhibitor for testing how ALK5–Smad2/3 signaling shapes fibrosis, renal injury, and diabetic wound repair. This article uses a 2026 bone-transport study to distinguish pathway correlation from causal assay design and translational interpretation.
-
Digoxin: From Ion Pump Biology to Translation
2026-08-26
Digoxin is more than a classic cardiac glycoside: it is a mechanistically defined Na+/K+ ATPase pump inhibitor that connects ion-gradient biology with cardiac contractility and cell-type-specific antiviral research. This article presents a translational framework for choosing models, controlling exposure, interpreting chikungunya findings, and advancing reproducible cardiovascular studies.
-
8-Chloroadenosine for RNA Stability Studies
2026-08-25
8-Chloroadenosine is a practical nucleoside analog for probing RNA synthesis, transcript stability, and transcriptional regulation in controlled cell-based workflows. This guide connects the reagent to the RP3-340N1.2–IL-6 axis in NSCLC while emphasizing assay design, handling, controls, and troubleshooting rather than overstating the reference study’s findings.
-
Dextromethorphan hydrobromide Research Workflows
2026-08-25
Build reproducible excitotoxicity and neuroprotection assays with Dextromethorphan hydrobromide, from concentration-response studies to electrophysiology and cerebral ischemia model planning. The workflow separates NMDA receptor effects from voltage-operated channel activity while applying a translational assay strategy informed by modern inhibitor discovery.
-
C8-HSL Links Quorum Sensing to Lung Cancer Progression
2026-08-24
The reference study identifies C8-HSL, a bacterial quorum-sensing molecule, as a direct promoter of lung cancer cell proliferation, migration, and invasion through PI3K/AKT/ERK signaling. Its combination of cell-based phenotyping, pathway analysis, and in vivo validation provides a mechanistic bridge between microbial signaling and tumor progression while remaining hypothesis-generating for human disease.